41st Annual J.P. Morgan Healthcare Conference
Safe Harbor / Non-GAAP financial measures
This presentation contains forward-looking statements within the meaning of the federal securities laws. Statements in
this presentation which are not strictly historical statements including, without limitation, express or implied
statements or guidance regarding Repligen's estimated financial results for full year 2022, future financial performance
and other statements identified by words like "estimated," "anticipated," "guidance," or "goal," and similar expressions
are forward-looking statements. These statements are subject to risks and uncertainties which may cause our plans to
change or actual results to differ materially from those anticipated. In particular, unforeseen events outside of our
control may adversely impact future results. Additional information concerning these factors is discussed in our reports
filed with the Securities and Exchange Commission including recent Form 8-Ks, our most recent Annual Report on Form
10K and our most recent Quarterly Reports on Form 100, all of which are available on our website. The forward-looking
statements in this presentation reflect management's current views and may become obsolete as a result of new
information, future events or otherwise. We may not update such forward looking statements to reflect a change of
events or circumstances that occur after the date hereof, except as required by law. The industry and market data
contained in this presentation are based on management's own estimates, independent publications, government
publications, reports by market research firms or other published independent sources, and, in each case, are believed
by management to be reasonable estimates. Although we believe these sources are reliable, we have not
independently verified the information. This presentation discloses certain financial measures not prepared in
accordance with generally accepted accounting principles, or GAAP. Repligen strongly encourages investors to review
our consolidated financial statements and publicly filed reports in their entirety and cautions investors that the non-
GAAP measures used herein may differ from similar measures used by other companies, even when similar terms are
used to identify such measures.
R REPLIGEN
2View entire presentation